Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Roivant Sciences (ROIV) Income from Continuing Operations (2020 - 2025)

Roivant Sciences (ROIV) has disclosed Income from Continuing Operations for 6 consecutive years, with 313701000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Income from Continuing Operations fell 50.14% year-over-year to 313701000.0, compared with a TTM value of 962596000.0 through Dec 2025, down 120.68%, and an annual FY2025 reading of 729764000.0, down 116.05% over the prior year.
  • Income from Continuing Operations was 313701000.0 for Q4 2025 at Roivant Sciences, down from 166039000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 5131180000.0 in Q4 2023 and bottomed at 684429000.0 in Q3 2021.
  • Average Income from Continuing Operations over 5 years is 78764000.0, with a median of 273911000.0 recorded in 2025.
  • The sharpest move saw Income from Continuing Operations plummeted 3332.99% in 2021, then soared 1433.13% in 2023.
  • Year by year, Income from Continuing Operations stood at 306085000.0 in 2021, then dropped by 25.75% to 384896000.0 in 2022, then skyrocketed by 1433.13% to 5131180000.0 in 2023, then plummeted by 104.07% to 208945000.0 in 2024, then crashed by 50.14% to 313701000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for ROIV at 313701000.0 in Q4 2025, 166039000.0 in Q3 2025, and 273911000.0 in Q2 2025.